Rodolphe THIEBAUT
University Hospital, Bordeaux · University Hospital Bordeaux, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rodolphe THIEBAUT as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 18:41 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03359642 · Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha TherapyUniversity Hospital, Bordeaux · completed · Spondyloarthritis, Crohn Disease, Ulcerative Colitis · study chair
- N/ANCT03078426 · Lung MRI in the Management of Idiopathic Pulmonary FibrosisUniversity Hospital, Bordeaux · completed · Idiopathic Pulmonary Fibrosis · study chair
- Ph3NCT02469753 · Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic OutcomesUniversity Hospital, Bordeaux · completed · Ankylosing Spondylitis · study chair
- Ph1/Ph2NCT02389231 · Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional TreatmentUniversity Hospital, Bordeaux · terminated · Autoimmune Hemolytic Anemia · study chair
- Ph4NCT02328963 · Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine AUniversity Hospital, Bordeaux · completed · Transplantation Infection, Cytomegalovirus Infection · study chair
- Ph1/Ph2NCT02320357 · Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus ErythematousUniversity Hospital, Bordeaux · completed · Systemic Lupus Erythematous · study chair
- N/ANCT02280902 · Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory DiseasesUniversity Hospital, Bordeaux · completed · Immunologic and Inflammatory Diseases · study chair
- N/ANCT02185677 · Cognitive and Behavioral Dysexecutive Syndrome in Multiple System AtrophyUniversity Hospital, Bordeaux · completed · Multiple System Atrophy · study chair
- N/ANCT02114242 · Biomarkers in Parkinsonian SyndromesUniversity Hospital, Bordeaux · unknown · Parkinsonian Syndromes, Parkinson's Disease, Multiple System Atrophy · study chair
- N/ANCT01992029 · Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral SclerosisUniversity Hospital, Bordeaux · terminated · Amyotrophic Lateral Sclerosis, ALS · study chair
- N/ANCT00273663 · Transcranial Electrical Stimulation (TCES) / Cerebral Blood Flow (CBF) / Xenon Under Computerized Tomography (Xe/CT)University Hospital, Bordeaux · completed · Healthy Volunteers · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 18:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 18:41 UTC. The ranking covers the 200 most relevant of 52 PubMed records, and a shared surname and initials can bring in a namesake. All 52 on PubMed
- Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.Lancet Infect Dis · 2011337 citationsRCR 10.8
- Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.J Clin Invest · 2009310 citationsRCR 6.5
- 193 citationsRCR 4.8
- Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.Lancet HIV · 2018191 citationsRCR 10.5
- Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.Lancet Infect Dis · 2021134 citationsRCR 6.8
- 133 citationsRCR 6.7
- PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.Lancet Infect Dis · 2020106 citationsRCR 5.3
- Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.Cell Rep · 2017104 citationsRCR 3.1
- Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load.Eur J Immunol · 201495 citationsRCR 2.5
- Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement.Ann Med · 200293 citationsRCR 2.4